{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:45:16Z","timestamp":1790185516247,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.semdp.2025.150893","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T08:14:36Z","timestamp":1741680876000},"page":"150893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An update on mixed phenotype acute leukemia"],"prefix":"10.1016","volume":"42","author":[{"given":"Olga K","family":"Weinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4543-272X","authenticated-orcid":false,"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon K","family":"Germans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.semdp.2025.150893_bib0001","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.semdp.2025.150893_bib0002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.semdp.2025.150893_bib0003","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022019493","article-title":"The international consensus classification of acute leukemias of ambiguous lineage","author":"Weinberg","year":"2023","journal-title":"Blood"},{"issue":"7727","key":"10.1016\/j.semdp.2025.150893_bib0004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.semdp.2025.150893_bib0005","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/bloodadvances.2018023531","article-title":"PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation","volume":"2","author":"Xiao","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.semdp.2025.150893_bib0006","article-title":"Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia","author":"Wang","year":"2022","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.semdp.2025.150893_bib0007","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ajh.25256","article-title":"Genomic and clinical characterization of B\/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations","volume":"93","author":"Mi","year":"2018","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.semdp.2025.150893_bib0008","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","article-title":"Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell leukemia","volume":"11","author":"Montefiori","year":"2021","journal-title":"Cancer Discov"},{"issue":"11","key":"10.1016\/j.semdp.2025.150893_bib0009","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2012.064485","article-title":"Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.semdp.2025.150893_bib0010","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semdp.2025.150893_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.12484","article-title":"Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview","volume":"163","author":"Manola","year":"2013","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150893_bib0012","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.semdp.2025.150893_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911259","article-title":"Genomic landscape of mixed-phenotype acute leukemia","volume":"23","author":"Hennawi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semdp.2025.150893_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107309","article-title":"Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: a study from the Bone Marrow Pathology Group","volume":"130","author":"Kirtek","year":"2023","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.semdp.2025.150893_bib0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajh.27537","article-title":"Acute leukemias of ambiguous lineage with MDS-associated mutations show similar prognosis compared to acute myeloid leukemia With MDS-associated mutations: a study from the bone marrow pathology group","volume":"100","author":"Kirtek","year":"2025","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150893_bib0016","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.semdp.2025.150893_bib0017","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12185-011-0953-1","article-title":"Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and\/or bcr-abl positive in adult","volume":"94","author":"Wang","year":"2011","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150893_bib0018","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/ejh.12343","article-title":"Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era","volume":"93","author":"Shimizu","year":"2014","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150893_bib0019","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1309\/AJCPSTU55DRQEGTE","article-title":"Acute leukemias of ambiguous origin","volume":"144","author":"Porwit","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150893_bib0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3324\/haematol.2016.151035","article-title":"ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype","volume":"102","author":"Hirabayashi","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.semdp.2025.150893_bib0021","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/cyto.b.21966","article-title":"Clinical and laboratory features associated with myeloperoxidase expression in pediatric B-lymphoblastic leukemia","volume":"100","author":"McGinnis","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"issue":"9","key":"10.1016\/j.semdp.2025.150893_bib0022","first-page":"773","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semdp.2025.150893_bib0023","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/s41375-020-0761-9","article-title":"T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T\/myeloid","volume":"34","author":"Wang","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.semdp.2025.150893_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International Consensus Classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"issue":"7380","key":"10.1016\/j.semdp.2025.150893_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semdp.2025.150893_bib0026","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.leukres.2018.05.009","article-title":"Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: a new ambiguous lineage subtype?","volume":"71","author":"Rossi","year":"2018","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.semdp.2025.150893_bib0027","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/cyto.b.21943","article-title":"Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics","volume":"100","author":"Panda","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"issue":"22","key":"10.1016\/j.semdp.2025.150893_bib0028","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1182\/blood-2018-09-871194","article-title":"Mixed-phenotype acute leukemia, T\/megakaryoblastic","volume":"132","author":"Klairmont","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.semdp.2025.150893_bib0029","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccr.2012.10.007","article-title":"An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia","volume":"22","author":"Gruber","year":"2012","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.semdp.2025.150893_bib0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.3772","article-title":"Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes","volume":"49","author":"de Rooij","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.semdp.2025.150893_bib0031","unstructured":"Borowitz MJ BM-C, Harris N.L., Porwit A., Matutes E., Arber D.A. . Acute leukaemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, and Siebert R. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th Edition. Lyon, France: IARC Press; 2017: 180\u2013187."},{"issue":"20","key":"10.1016\/j.semdp.2025.150893_bib0032","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semdp.2025.150893_bib0033","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-022-03430-4","article-title":"The International Consensus Classification of acute myeloid leukemia","volume":"482","author":"Weinberg","year":"2023","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.semdp.2025.150893_bib0034","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cyto.b.21783","article-title":"Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia","volume":"96","author":"Porwit","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"issue":"6","key":"10.1016\/j.semdp.2025.150893_bib0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11899-018-0479-1","article-title":"Minimal\/measurable residual disease detection in acute leukemias by multiparameter flow cytometry","volume":"13","author":"Fuda","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"issue":"4","key":"10.1016\/j.semdp.2025.150893_bib0036","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ajcp\/aqx021","article-title":"Clinical significance of isolated myeloperoxidase expression in pediatric B-lymphoblastic leukemia","volume":"147","author":"Oberley","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150893_bib0037","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2017-09-807602","article-title":"Isolated myeloperoxidase expression in pediatric B\/myeloid mixed phenotype acute leukemia is linked with better survival","volume":"131","author":"Raikar","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semdp.2025.150893_bib0038","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ijlh.13988","article-title":"Adult mixed phenotype acute leukemia (MPAL): b\/myeloid MPAL(isoMPO) is distinct from other MPAL subtypes","volume":"45","author":"Weinberg","year":"2023","journal-title":"Int J Lab Hematol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150893_bib0039","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41375-018-0058-4","article-title":"Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis","volume":"32","author":"Maruffi","year":"2018","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.semdp.2025.150893_bib0040","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood-2014-10-551465","article-title":"How I treat mixed-phenotype acute leukemia","volume":"125","author":"Wolach","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semdp.2025.150893_bib0041","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cncr.32552","article-title":"Mixed-phenotype acute leukemia: a cohort and consensus research strategy from the children's oncology group acute leukemia of ambiguous lineage task force","volume":"126","author":"Orgel","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.semdp.2025.150893_bib0042","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/blood-2017-12-821363","article-title":"International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia","volume":"132","author":"Hrusak","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semdp.2025.150893_bib0043","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MOH.0000000000000570","article-title":"Optimal therapeutic strategies for mixed phenotype acute leukemia","volume":"27","author":"Wolach","year":"2020","journal-title":"Curr Opin Hematol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257025000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257025000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:07:09Z","timestamp":1745978829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257025000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0740257025000292"],"URL":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150893","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on mixed phenotype acute leukemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150893"}}